COLOMBO NICOLETTA
Pubblicazioni
De Vitis, L., Schivardi, G., Gaeta, A., Caruso, G., Rosanu, M., Ribero, L., et al. (2025). External validation of the Annual Recurrence Risk Model (ARRM) for tailored surveillance strategy in patients with cervical cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER [10.1016/j.ijgc.2025.101756]. Dettaglio
Grisham, R., Monk, B., Van Nieuwenhuysen, E., Moore, K., Fabbro, M., O'Malley, D., et al. (2025). GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: A phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER [10.1136/ijgc-2024-005919]. Dettaglio
Scambia, G., Villalobos Valencia, R., Colombo, N., Cibula, D., Leath, C., Bidzinski, M., et al. (2025). Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results. JOURNAL OF CLINICAL ONCOLOGY, 43(12) [10.1200/JCO.24.00933]. Dettaglio
Oaknin, A., Monk, B., de Melo, A., Kim, H., Kim, Y., Lisyanskaya, A., et al. (2025). Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial. EUROPEAN JOURNAL OF CANCER, 216(5 February 2025) [10.1016/j.ejca.2024.115146]. Dettaglio
Quesada, S., Penault-Llorca, F., Matias-Guiu, X., Banerjee, S., Barberis, M., Coleman, R., et al. (2025). Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics. EUROPEAN JOURNAL OF CANCER, 215(17 January 2025) [10.1016/j.ejca.2024.115169]. Dettaglio